LungStage Pro
Built for thoracic MDTs · HL7 FHIR R4
The operating system for modern thoracic oncology.
From referral to follow-up, every case moves through one MDT board — staged on IASLC 9th edition, with operative risk and treatment guidance built in.
Four decisions, one pathway.
- Staging — cTNM and pTNM on the IASLC 9th edition, with stage migration shown explicitly and every descriptor traceable.
- Operative risk — predicted morbidity and mortality in natural frequencies (Eurolung, ThRCRI, ppoFEV₁/DLCO) — never a single false-precision number.
- Treatment planning — guideline-aligned options per stage with the pivotal evidence (NICE, ESMO, CheckMate 816, KEYNOTE-671) linked beside the recommendation.
- MDT workflow — one board from referral to follow-up; outcomes, actions and owners captured as the meeting runs, ready to audit.
It reads from the record you already use.
LungStage imports from the EHR over HL7 FHIR R4, with SNOMED CT coding on the way in — staging and risk calculated on record data, no parallel database. Import only; nothing is written back.
Built to pass information governance.
Role-based access with accounts managed in LungStage, a full exportable audit trail, and the MDT in control of every recommendation.
Every output traces to a source.
Clinical algorithms drawn from the authoritative sources in thoracic oncology: IASLC 9th edition, ESTS, ERS, NICE and ESMO, with Eurolung and ThRCRI risk models. Built by Mr Alessandro Maraschi, MD FRCS (Eng), Consultant Thoracic & Robotic Surgeon.